Rhythm Pharmaceuticals, Inc. RYTM Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s common stock?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported common stock of 120M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s common stock increased by 193448.4% year-over-year, from 62K to 120M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s common stock has grown at a 386.6% compound annual growth rate (CAGR), from 44K to 120M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).